Drugs / autologous decidual-like NK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06821685 | Feb 2025 → Jul 2027 expected | female infertility, habitual spontaneous abortion, low implantation of placenta, preeclampsia | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous decidual-like NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06821685 ↗ |
| Modality | Cell therapy | “autologous decidual like NK cells will be isolated and induced in vitro culture from the patients' peripheral blood and perfused into their uterine.” NCT06821685 ↗ |
| Route | Other | “intrauterine infusion” NCT06821685 ↗ |